What did the FDA find wrong with Targeted Medical Pharma, Inc. dba Physician Therapeutics?

The FDA issued a warning letter citing labeling violations related to their products or manufacturing practices.

Are Targeted Medical Pharma, Inc. dba Physician Therapeutics products safe to use?

Based on the FDA's findings, consumers should exercise caution. The company was found to have labeling violations that may affect product safety.

What should I do if I've used Targeted Medical Pharma, Inc. dba Physician Therapeutics products?

If you have used products from Targeted Medical Pharma, Inc. dba Physician Therapeutics and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.

Targeted Medical Pharma, Inc. dba Physician Therapeutics FDA

Name: Targeted Medical Pharma, Inc. dba Physician Therapeutics FDA
Creator: Supplement Safety Data Team
Published: 2026-03-27T01:44:17.270576

Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on March 29, 2017

MODERATE SEVERITY Center for Drug Evaluation and Research 2017

Disclaimer: This report is an analysis of a public FDA warning letter. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately.

Executive Summary

The FDA issued a warning letter to Targeted Medical Pharma, Inc. dba Physician Therapeutics on March 29, 2017 citing labeling violations. The letter was issued by Center for Drug Evaluation and Research.

Labeling Violations

Detailed Analysis

False Claims and Regulatory Violations

The FDA identified regulatory violations in Targeted Medical Pharma, Inc. dba Physician Therapeutics's operations or product claims.

Potential Health Risks

The investigation does not involve a route of administration, dosage level, use in a patient population, or other factor that significantly increases the risks (or decreases the acceptability of the risks) associated with the use of the drug product;

Regulatory Context

The investigation is conducted in compliance with the requirements for institutional review set forth in 21 CFR 56 and with the requirements for informed consent set forth in 21 CFR 50; and

The investigation is conducted in compliance with the requirements of 21 CFR 312.7.

Key Entities Identified

21 CFR 56 21 CFR 50 21 CFR 312.7

Frequently Asked Questions

What did the FDA find wrong with Targeted Medical Pharma, Inc. dba Physician Therapeutics?: The FDA issued a warning letter citing labeling violations related to their products or manufacturing practices.
Are Targeted Medical Pharma, Inc. dba Physician Therapeutics products safe to use?: Based on the FDA's findings, consumers should exercise caution. The company was found to have labeling violations that may affect product safety.
What should I do if I've used Targeted Medical Pharma, Inc. dba Physician Therapeutics products?: If you have used products from Targeted Medical Pharma, Inc. dba Physician Therapeutics and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.

Source Document

This report is based on an official FDA warning letter. The original document is a public record.

View Original FDA Warning Letter

Medical Disclaimer: This report is an analysis of public FDA warning letters. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately. You can report adverse events to the FDA MedWatch program.